LEAP2 and bacterial infectious disease: In response to bacterial infection, LEAP-2 is induced in the liver, small intestine, immune tissues (e.g., bone marrow and tonsil) (15–17), as well as cerebrospinal fluid (CSF) of patients with bacterial meningitis (18).